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The protein tyrosine kinase Syk plays a critical role in FcεRI signaling in mast cells. Binding of Syk to phosphorylated immunore-
ceptor tyrosine-based activation motifs (p-ITAM) of the receptor subunits results in conformational changes and tyrosine
phosphorylation at multiple sites that leads to activation of Syk. The phosphorylated tyrosines throughout the molecule play
an important role in the regulation of Syk-mediated signaling. Reconstitution of receptor-mediated signaling in Syk−/− cells by
wild-type Syk or mutants which have substitution of these tyrosines with phenylalanine together with in vitro assays has been
useful strategies to understand the regulation and function of Syk.
1.Introduction
The clustering of the high-aﬃnity receptor for IgE (FcεRI)
initiates a series of biochemical events in mast cells or
basophilsthat culminatewith therelease ofpreformed medi-
atorsfrom granulestogetherwith the synthesis and release of
lipid mediators and cytokines [1–6]. The FcεRI is a member
of a larger family of multisubunit immune recognition
receptors (MIRRs), which also includes the T-cell receptor
(TCR), the B-cell receptor (BCR), and some other Fc
receptors (FcR) like FcγRI and FcγRIII [7]. These receptors
have no intrinsic catalytic activity. Instead, their activation
results in phosphorylation of the two tyrosines in the ITAM
(immunoreceptor tyrosine-based activation motif) within
the cytoplasmictailsofsubunitsofthe receptor. ITAM-based
signaling shares a common signal transduction mechanism,
where the recruitment and activation of Syk or ZAP-70 is
a critical step for these immunoreceptors to activate these
cells [8, 9]. This paper summarizes important studies and
new ﬁndings on regulation and function of Syk in mast cell
signaling and some other cells.
2.Syk-Mediated FcεRIActivation
FcεRI is a tetrameric structure formed by the complex αβγ2
chains. The α-subunit binds the Fc portion of IgE at a ratio
of 1:1 while the β-subunit and the disulphide-linked γ-
subunits contain ITAMs in their cytoplasmic tail [5, 10].
Aggregation of FcεRI results in phosphorylation of the
tyrosineswithintheITAMsbyLyn,oranothermemberofthe
Srcfamily of tyrosine kinases thatassociate with the receptor.
Phosphorylated ITAM then serves as a docking site for Syk;
this binding of Sykthroughits SH2domains results in acon-
formational changeofSykwhich allowstrans-a n da ut o ph o s -
phorylation of its catalytic domain, as well as phosphoryla-
tionbyLyn,therebyincreasing Sykenzymaticactivity[2,11].
Tyrosine-phosphorylated Syk leads to downstream prop-
agation of signaling with phosphorylation of linker for acti-
vation of T cells (LAT), Vav, BTK, phospholipase Cγ (PLCγ),
and SH2 domain-containing leukocyte protein of 76kDa
(SLP-76) [12, 13]. Phosphorylated LAT functions as a sig-
nal platform providing binding sites directly for growth fac-
tor receptor-bound protein 2 (Grb2), Grb2-related adaptor2 Journal of Signal Transduction
downstream of Shc (Gads), and PLCγ, while indirectly bind-
ing for SLP-76, NCK, and other adaptors. PLCγ hydrolyzes
phosphatidylinositol 4,5-bisphosphate (PIP2)i nt h ep l a s m a
membrane to producediacylglycerol, which activatesprotein
kinase C (PKC), and inositol 1,4,5-triphosphate (IP3)[ 6,
14]. The binding of IP3 to its receptor in the endoplasmic
reticulum (ER) membrane rapidly induces the ﬁrst stage of
calcium (Ca2+) mobilization, which is the transient release
of Ca2+ from ER stores. The depletion of calcium in the
ER induces formation of multimers of Stim1in the ER
membrane, which move and interact directly with Orai1, a
pore subunit of the Ca2+ channel, in the plasma membrane.
Together with calcium released from ER, this induces pro-
longed Ca2+ inﬂux through store-operated calcium release-
activatedcalcium(CRAC)channels intheplasma membrane
[15, 16]. Syk-mediated tyrosine phosphorylation of BTK,
SLP-76, LAT, and PLCγ is essential to generate signals for
sustained Ca2+ inﬂux. All these events culminate with mast
cell degranulation, phosphorylation of MAP kinases, and
activation of nuclear factor for T-cell activation (NFAT) and
nuclear factor κB( N F κB), which turn on cytokine synthesis.
3.The SykTyrosine Kinase
Syk gene was ﬁrst cloned on the basis of partial sequenced
information of the 40kDa kinase from a porcine spleen.
The product of this gene was described as a member of
a new nonreceptor-type protein tyrosine kinase of 72kDa
(p72syk). Interestingly, unlike src family protein kinases,
p72syk has a second SH2 instead of an SH3 domain [17].
Molecular cloning then described a gene that encoded a
70kDa protein tyrosine kinase associated with the ζ chain
of the T-cell receptor, termed ZAP-70 [18]. This also had
two SH2 domains and was very similar to p72syk.T h o s e
ﬁndings indicatedthat SykandZAP-70belongedtoadistinct
subfamily of nonreceptor protein tyrosine kinases [19],
named Sykfamily ofprotein kinases. Sykisexpressed in mast
cells, B cells, immature T cells, and platelets, whereas ZAP-70
is in T cells and natural killer cells [18, 20]. Structurally, both
Syk and ZAP-70 have two Src-homology 2 domains (SH2)
and a kinase domain. The interdomain A is located between
the NH2-terminal SH2 (SH2-N) and COOH-terminal SH2
(SH2-C), while interdomain B or linker region is between
the SH2-C and the kinase domains; following the kinase
domainthere isa short COOH-terminal extension (tail)[21]
(Figure 1).
In vivo,Sykhasbeenreported tobeessential in maintain-
ing vascular integrity and wound healing during embryoge-
nesis. Syk−/− mice showed petechiae, suﬀered severe hem-
orrhaging as embryos, and died perinatally [22, 23]. Also,
irradiated mice reconstituted with Syk-deﬁcient fetal liver
showed a block in B-cell development and maturation [23].
In cells, Syk plays an essential role in IgE-mediated acti-
vation of mast cells. Syk−/− mast cells are unable to induce
Ca2+ mobilization,degranulate,phosphorylateMAPkinases,
and activate NFAT or NFκB; but transfection of these cells
with Syk reconstitutes their activation [24–26]. Similarly,
BCR crosslinking in Syk−/− B cells also fails to induce cell
activation [27]. Recent studies have shown that bone mar-
row-derived mast cell (BMMC) treated with siRNA targeted
to Syk eﬃciently decreases receptor-induced cell activation
[2, 28].
Due to structural similarities Syk and ZAP-70 have also
some functional redundancies. For example, expression of
either ZAP-70 or Syk reconstitutes receptor-induced cell
activation in Syk-negative mast cells and B cells [26, 27, 29];
however, ZAP-70 but not Syk requires CD45 to eﬃciently
induce FcεRI-induced signaling responses in Syk-negative
mast cells [29]. Additionally, in CD45-deﬁcient T cells, Syk
but not ZAP-70 restores the TCR signaling pathway [30].
CD45 is a critical component of TCR, acting as a positive
regulator of Src family protein tyrosine kinases, such as Lck.
Activation of TCR leads to dephosphorylation of negative
sites of Lck which then activates ZAP-70. These studies
demonstratethatbindingofSyktothephosphorylatedITAM
is enough to trigger its enzymatic activity while ZAP-70
requires an additional stimulatory input from other tyrosine
kinases.
4.Phosphorylated ITAM-Induced
Syk Activation
ITAM-based signalinghasbeenextensivelycharacterizedand
serves as a model for receptor-mediated signal transduction
[8, 9]. The ITAM consensus sequence is D/E-(X)2-Y-(X)2-
L/I-(X)6/7-Y-(X)2-L/I, where the two tyrosines residues are
phosphorylated upon receptor activation. The β-a n dγ-
subunits of FcεRI complex contain ITAM on their cyto-
plasmic tails. Phosphorylated ITAM (p-ITAM) serves as the
docking site for the two SH2 domains of Syk [31–34]. The
association of Syk with p-ITAM occurs with an antiparallel
binding orientation: the SH2-N of Syk binds to the COOH-
terminal phosphotyrosine of the ITAM while the SH2-
Cb i n d st ot h eN H 2-terminal phosphotyrosine [31, 32]
(Figure 2). In vitro experiments using synthetic peptides
corresponding to the β-o rγ-ITAM of FcεRI showed that
Syk binds preferentially to the biphosphorylated γ-ITAM
[32]. The SH2 domain-mediated binding of Syk/ZAP-70 to
phosphorylated ITAM in subunits of immune receptors is
critical for activation of these cells; the expression in cells
of truncated Syk containing just the two SH2 domains has
a dominant-negative eﬀect that inhibits binding of endoge-
nous Syk and decreases receptor signaling [35]. Although
both SH2 domains of Syk are required for its binding to
p-ITAM, the SH2-C binds stronger to the phosphorylated
γ-ITAM than the SH2-N. The binding of Syk to the p-
ITAM results in conformational changes of Syk exposing
its COOH-terminal region [36] by disrupting the COOH-
terminal/SH2-interdomain interactions [37, 38]. Interaction
of the COOH-terminal with SH2 interdomain stabilizes
the autoinhibitory structure of the enzyme; the binding
to p-ITAM induces a conformational change that “opens”
the molecule resulting in Syk activation [25]. In addition,
Syk itself can phosphorylate the ITAMs creating a positive
feedback loop during the initial steps of receptor-mediated
Syk activation [39]( Figure 2).Journal of Signal Transduction 3
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Figure 1: Structure of protein tyrosine kinase Syk: (a) a schematic diagram of the linear structure of Syk with the tyrosines marked that are
phosphorylated after its in vitro activation. In the linker region there are 23 amino acids which are missing in SykB. (b) Suggested globular
structure of autoinhibited (left) and activated (right) Syk with some phosphorylated tyrosines indicated.
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Figure 2: ITAM-based Syk activation: activation of the immunoreceptor, here represented by a γ-subunit of FcεRI, results in the
phosphorylation of the ITAMs by Lyn or other Src kinase that associates with the receptor. This recruits the cytoplasmic Syk which binds to
the phosphorylated ITAM (p-ITAM) resulting in conformationalchanges that disrupt its autoinhibited structure, which increase the kinase
activity of Syk. After activation, Syk is tyrosine phosphorylated essentially by trans- or autophosphorylation with some participation of
other tyrosine kinases.The phosphorylation of Tyr-130 releases the kinasefrom the receptor allowing Syk to phosphorylate its targets in the
cytoplasm of the cell.
5.Autoinhibitionof Syk/Zap-70
Structural studies of ZAP-70 suggest an autoinhibitory state
for Syk family kinases [37, 38]. Several tyrosine residues
throughoutthemoleculecanregulateSyk/ZAP-70enzymatic
activity; phosphorylation of these can stabilize the active
form, whereas in the nonphosphorylated state the same
residues may contribute to autoinhibition of the enzyme. In
the inactive ZAP-70, the hydrogen-bonding network is stabi-
lized by a hydrophobic cluster formed by Pro-396, Tyr-397,
and Tyr-474 in the kinase domain and Tyr-319 in the linker
region, whereas, in the active form, the hydrogen-bonding
network and hydrophobic interactions are disrupted [37].
This structural study of ZAP-70 was with a protein that had
theCOOH-terminalregionmissing, andthecrystalstructure
of only the SH2 domains of Syk has been determined. How-
ever,itispredictedthatthetwotyrosinesinthetailofZAP-70
interact with the α-helix of the C-lobe of the kinase domain
and the inter-SH2 domain regions; these interactions help to
stabilize the autoinhibitory form of Syk/ZAP-70 [25, 38].4 Journal of Signal Transduction
6.RegulationofSykFunctionby Its
Tyrosine Phosphorylation
Activation of Syk leads to its tyrosine phosphorylation due
mostly to autophosphorylation with some contribution by
other tyrosine kinases [40]. Analysis of activated Syk has
indentiﬁed ten tyrosines residues which are autophosphory-
lated in vitro [41]( Figure 1); several of these are also found
phosphorylated in mast cells after receptor activation [42].
These phosphotyrosines can regulate Syk function and also
generate potential docking sites for other molecules.
One of these phosphotyrosines at Tyr-130 is located in
the inter-SH2 domain and is an early site of Syk autophos-
phorylation. Phosphorylation of Tyr-130 regulates the bind-
ing of Syk to the p-ITAM by dissociating Syk from the
receptor. Substitution of Tyr-130 with Phe enhances binding
of Syk to the receptor while this is greatly reduced by
substitution with Glu [43, 44]. Studies also suggest that
phosphorylation of Tyr-130 destabilizes inter-SH2 domain
structure, which alters the orientation and increases the
distance between the two SH2 domains beyond the limit
permitted for their functional binding to p-ITAM [44].
The linker region plays a critical role in regulation of Syk
function. An alternative spliced form of Syk, named SykB,
lacks 23 amino acids, known as “linker insert,” in the linker
region (Figure 1). This linker insert enhances the binding
of Syk to the p-ITAM, which helps to explain why SykB is
ineﬃcient in reconstituting FcεRI signaling in Syk-deﬁcient
mast cells [45]. Within the linker insert is Tyr-290, which
is autophosphorylated in vitro [41]. Substitution of Tyr-290
of Syk with Phe does not aﬀect Syk-mediated downstream
signaling of either FcεRI or TCR [45]. Also, BCR-mediated
NFAT activation in Syk-deﬁcient DT40 cells expressing Syk-
Y290Fwassimilartocellswithwild-typeSyk[46].Therefore,
Tyr-290 has no obvious eﬀect on Syk-mediated signaling.
Three conserved tyrosines, Tyr-317, Tyr-342, and Tyr-
346, are located in the linker region. These are found phos-
phorylated in both Syk and ZAP-70 after receptor activation
[42, 47]. It has been reported that Tyr-317 is a negative regu-
latory site of Syk function [48]. Substitution of Tyr-317 with
Pheincreases Sykkinaseactivityanditsautophosphorylation
capacity. In vivo, expression of Syk-Y317F enhances mast cell
degranulation and phosphorylation of PLCγ1a n dP L C γ2
without aﬀecting its binding to the p-ITAM [48]. Also,
expression of Syk-Y317F in DT40 B cells enhances BCR-
mediated activation of both transcription factors NFAT and
Elk-1 [49]. Phosphorylation of Tyr-317 not only negatively
regulates Syk function but also creates a binding site for
proteinubiquitinligases ofCblfamily, which targetreceptors
and tyrosine kinases [50]. Among the three members of
Cbl family proteins two of them, c-Cbl and Cbl-b, are
expressed in hematopoietic cells [51]. The absence of Cbl-b
enhances mast cell degranulation, Ca2+ inﬂux, and synthesis
of cytokines such as TNF-α and IL-6 [52, 53]. These are
mostly due to increased phosphorylation of both Syk and
receptor phosphorylation in Cbl-b−/− mast cells. Studies
using c-Cbl−/− mast cells show that c-Cbl has more eﬀect
on phosphorylation of MAP kinases but does not aﬀect Syk
phosphorylation [53].Therefore phosphorylation ofTyr-317
negatively regulates Syk function, and this also creates a
binding site for Cbl-b which leads to ubiquitination and
degradation of Syk.
Tyrosines 342 and 346 are phosphorylated after receptor
activation in mast cells [54]. These tyrosines have been
reported to be involved in the interaction of Syk with PLCγ
and Vav. Thus, in COS cells expression of Syk with both
Tyr-342 and Tyr-346 mutated to Phe results in loss of
interaction of Syk with PLCγ [55]. Experiments using two-
hybrid system suggest that phosphorylated Tyr-342 of Syk is
ab i n d i n gs i t ef o rV A V[ 56]. Functional analysis of each of
these tyrosines shows that substitution of Tyr-346 with Phe
impairs Syk-mediated phosphorylation of SLP-76, LAT, and
PLC-γ2, calcium mobilization, and mast cell degranulation
[54]. This can be as a result of decreased kinase activity
and reduced binding of mutated Syk to phosphorylated γ-
ITAM. Interestingly, Tyr-346 substitution with Phe has min-
imal eﬀects on receptor-mediated mast cell degranulation.
Another tyrosine phosphorylated in the linker region is Tyr-
358. This is autophosphorylated in vitro [41]; but there have
been no reports on the role of Tyr-358 in Syk function.
Aggregation of FcεRI results in phosphorylation of two
adjacent tyrosines in the activation loop of Syk kinase do-
main, Tyr-519/Tyr-520. Both of these are essential for Syk-
mediated receptor signaling in mast cells [57]. Tyr-519 has
more impact on histamine release, while Tyr-520 is more
involved in phosphorylation of PLCγ2. However, in vitro
experiments show that substitution of one or both of these
activation loop tyrosines with Phe does not aﬀect the kinase
activity of Syk nor its binding to the p-ITAM [57]. Other
studies demonstrate that the binding of mAb AA4, an anti-
body that recognizes a mast cell-speciﬁc ganglioside on the
cell surface [58], results in the strong tyrosine phosphory-
lation of cellular proteins including Syk, but not histamine
release or phosphorylation of the activation loop tyrosines
[40]. It is suggested that phosphorylation of the activation
loop tyrosines occurs mostly by auto-transphosphorylation
with some participation of other tyrosine kinases in the
initiation ofthe phosphorylation process[40, 59].Therefore,
the phosphorylation of activation loop tyrosines is critical
for Syk-mediated FcεRI signaling in mast cells. Unlike Syk,
mutation of Tyr-493, analogous to Tyr-520 of Syk, abrogates
the in vitro kinase activity of ZAP-70 [60]. This disparity in
the in vitro function of the activation loop tyrosines of Syk
and ZAP-70 can be explained by diﬀerencesin the enzymatic
activity of both proteins. For example, the kinase activity of
ZAP-70 but not Syk depends on the presence of Lck for its
initial activation, and the enzymatic activity of Syk is at least
100-fold greater than that of ZAP-70 [57, 60, 61].
The COOH-terminal region of Syk has three conserved
tyrosines (Tyr-623, Tyr-624, and Tyr-625); the last two of
which are also conserved in human ZAP-70 [25]. Tyr-624
and Tyr-625 are phosphorylated in both Syk and ZAP-
70 by in vitro autophosphorylation or following receptor
stimulation [41, 42, 62, 63]. Mutation of these three Tyr to
Phe disruptstheautoinhibitorystateofSykwhich allowsitto
be more tyrosine phosphorylated by another tyrosine kinase
in cells, which activates Syk and results in autophosphoryla-
tion[25].Withoutsuchphosphorylation byanothertyrosineJournal of Signal Transduction 5
kinase, these mutations result in Syk that has very low en-
zymatic activity and capacity for autophosphorylation.
Therefore, mutation of these tyrosines results in Syk which
functionally is more similar to ZAP-70 in its requirement
for another tyrosine kinase for activation. In mast cells
this mutated Syk is less eﬃcient in FcεRI signaling because
of decreased binding to phosphorylated ITAM indepen-
dent of phosphorylation of Tyr-130. Together with the
decreased kinase activity, this leads to reduced mast cell
degranulation, decreased phosphorylation of MAP kinases,
and lower activation of NFAT and NFκB. Other results
strongly suggest that phosphorylation of COOH-terminal
tyrosines of Syk creates a docking site for SLP-65 in B
cells, although it is not clear if this is a result of direct
binding or if other adaptors could mediate this interaction
[63].
7.Direct and Indirect NegativeRegulationof
SykSignaling
The regulation of Syk function also includes the downreg-
ulation of its activity after receptor activation; this process
involves the participation of protein phosphatases and
ubiquitin ligases. Cbl-b-mediated Syk ubiquitination and
degradation has been the most characterized mechanism to
downregulate Syk function in receptor signaling (previously
discussed). The phosphatases SHIP1, SHP1, and SHP2 are
tyrosine phosphorylated after FcεRI aggregation, and this
phosphorylation is independent of Syk. These phosphatases
arefoundassociated with FcεRIinmast cells[64,65].In vitro
experiments show that both SHP1 and SHP2 dephosphory-
late β-a n dγ-subunits of the FcεRI [65]. These phosphatases
indirectly inhibit Syk function by limiting the intensity and
duration of receptor phosphorylation which, as discussed
above, leads to Syk activation. Recently, a novel histidine
tyrosine phosphatase, T-cell ubiquitin ligand-2 (TULA-2),
has been described to associate with Syk [66]. TULA-
2, also known as ubiquitin-associated domain and SH3
domain-containing protein B (UBASH3B) or suppressor of
T-cell receptor signaling-1 (Sts-1), belongs to the TULA-
family of proteins [67, 68]. It has been shown that TULA-
2 targets phosphotyrosines 317, 346, and 519/520 of Syk
[69]. Additionally, Syk has increased phosphorylation in
GPVI-stimulated platelets from TULA-deﬁcient mice or by
inhibiting TULA-2 activity in 293T cells [66, 69, 70]. T cells
from TULA−/− mice are hyperresponsive toTCRstimulation
as a result of increased activation of ZAP-70 [71]. These
ﬁndings strongly suggest that TULA-2 is a phosphatase
which directly downregulates the activity of Syk family pro-
teins.
8.Syk-Mediated ActinRedistributionin
Mast Cells
The RBL-2H3, a mast cell line, has been widely used as a
m o d e lt os t u d yF c εRI-mediated signaling. Morphological
studies show that resting RBL-2H3 cells are normally spindle
shaped with small microvilli on their surface; these cells
become ﬂattened and spread and their surfaces are ruﬄed
and plicated after receptor activation [58]. These mor-
phological changes involve redistribution of actin and are
in parallel with mediator release. Some other experiments
demonstrate that these morphological changes are down-
stream of Syk and are Ca2+ dependent [2, 72]. For example,
activation of FcεRI induces minimal or no morphological
change in RBL-2H3 Syk−/− variant mast cell line; but this
is reconstituted by stable expression of Syk in these cells.
Additionally, receptor-mediated redistribution of actin is
observed only in cells expressing Syk after transient trans-
fection of Syk−/− cells (Figure 3). Therefore, the cellular
mechanisms which result in morphological changes in mast
cells are dependent on Syk activation.
9.New StudiesonSykFunction
Receptor-induced Syk tyrosine phosphorylation has been
well characterized in hematopoietic cells [2, 12, 13, 38, 73].
However, there islittleinformation on Sykbeing phosphory-
latedonSer/Thrresidues.Recently,aninterestingstudyusing
phosphopeptide mapping and mass spectrometric analyses
identiﬁed a new phosphorylated residue in the linker region
of Syk, Ser-291 [46]. This is phosphorylated by PKC after
BCR activation or PMA treatment in the Syk-deﬁcient DT40
cells expressing Syk-EGFP. Substitution of Ser-291 with Ala
decreases Syk-mediated BCR signaling to activate NFAT and
Elk-1 but does not aﬀect Syk kinase activity [46]. In ZAP-
70, Ser-520 was predominantly phosphorylated in normal T
lymphocytes and Jurkat T cells. Substitution of Ser-520 with
Ala reduced the capacity of ZAP-70 to autophosphorylate
and to mediate TCR-induced IL-2 promoter activation [74].
Recently,itwasdemonstratedthatSer-197inthecytoplasmic
tail of Ig-α is phosphorylated upon BCR activation which
inhibits signaling [75]. Surprisingly, this study suggests
that Syk is the kinase responsible for phosphorylating Ser-
197 of Ig-α, indicating a dual-speciﬁcity kinase activity for
Syk.
10.Conclusion
Studies have shown that Syk is a key player in mast cells and
other hematopoietic cells. Severalstudies have also suggested
themechanisms thatregulateSykfunctionbasedonitsstruc-
ture and phosphorylated tyrosines. Mutating Syk has been
the strategy most frequently used to understand its func-
tion but, surprisingly, this could aﬀect the autoinhibitory
structure of the molecule resulting in secondary eﬀects. For
example, mutations of the three conserved tyrosines in the
COOH-terminal region of Syk decreases its binding capacity
to the p-ITAM due to decreased autoinhibitory structure of
mutated Syk and not because of the mutation itself [25].
Also, Syk carrying either a green ﬂuorescence protein (GFP)
domain or an aﬃnity tag at the NH2-o rC O O H - t e r m i n a l
s e e m st ob em o r ea c t i v et h a nw i l d - t y p eS y k[ 38, 63]. This
could result in some nonspeciﬁc activities of the molecule
when expressed in cells. Understanding Syk function and6 Journal of Signal Transduction
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Figure 3: Reconstitution of Syk-mediated actin redistribution in Syk−/− mast cells: C4A2 Syk−/− mast cells were transfected with empty
plasmids or plasmids that express wild-type Syk [25]. These cells were cultured with antigen-speciﬁc IgE, washed, and then either incubated
with medium alone ((a) and (c)) or medium containing antigen. After 10min, the cells were immunostained as described previously [76]
usingmAbanti-Syk (26B61A6)andF(ab
 )2 donkeyantimouseIgG conjugated with Alexa 488;actin stainingwaswith phalloidinconjugated
with Alexa-633. In nonactivated Syk−/− cells transfected with empty vector (a) or wild-type Syk (c), actin was uniformly distributed on the
cell periphery (arrow). After receptor activation, in these cells expressing wild-type Syk ((d), arrow), there was redistribution of actin which
follows the ruﬄed cell membrane, characteristic of activated mast cells; while minimal or no redistribution of actin was observed in cells
that did not express Syk ((d), asterisk) or in cells transfected with empty vector (b). In nonstimulated cells expressing wild-type Syk, the Syk
was found throughout the cytoplasm ((c), arrow head); after receptor activation, part of the cytoplasmic Syk was recruited to the plasma
membrane and colocalized with actin ((d), arrow head). Bar: 10μm.
its interactions is important for developing pharmacological
compounds that regulate its function.
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